the rigid age exclusion criterion will be use because the majority of incl patient have more frequent seizure complete retinal blindness and significant cerebral atrophy beyond 3 year of age dr. santavuori one of our consultant who be now decease who have the most extensive experience with these patient believe that the neurological degeneration after age 2 might not be reversible while dr. santavuori s speculation be well take we feel that since to date there have not be any effective treatment to slow the progression of neuronal death in incl and since our preliminary result show that cystagon slow the progression of neurodegeneration we feel that a combination of cystagon plus n-ac with it anti-apoptotic and neuro-protective effect may show some add benefit over cystagon therapy alone 